Mastery EAQ Ch. 20

A  Administer after meals.

B  Administer 30 minutes before meals.

C  Administer after dissolving in water.

D  Administer with fruit juices.

A  Hyperthyroidism, Coronary artery disease, Emphysema, Type 2 diabetes mellitus

B  Peptic ulcer, Parkinsonism, Hyperthyroidism, Coronary artery disease

C  Emphysema, Type 2 diabetes mellitus, Parkinsonism, Hyperthyroidism,

D  Emphysema, Type 2 diabetes mellitus, Peptic ulcer, Parkinsonism,

A  “This medication will increase your ability to sleep without dreaming.”

B  “This medication will enhance your memory.”

C  “You will only need to take this medication for 3 months.”

D  “This medication should cure your Alzheimer’s disease.”

A  Dopamine

B  Atropine

C  Epinephrine

D  Lidocaine

A  Elevated heart rate

B  Pupil constriction

C  Decreased heart rate

D  Pupil dilation

A  Increased muscle strength

B  Moist oral mucous membranesn

C  Relief of dry skin

D  Improved vision

A  No longer dizzy

B  Increased muscle strength

C  Able to walk long distances

D  Improved memory

A  Hypertension and Syncope

B  Constipation and Mydriasis

C  Hair loss and Mydriasis

D  Hair loss and Constipation

A  Assessment of bowel sounds

B  Assessment of blood pressure

C  Administration of another dose in an hour

D  Administration of a second drug

A  Decreased gastric motility and Decreased sweat gland secretion

B  Decreased heart rate and Increased respiratory secretions

C  Decreased gastric motility and Pupil dilation

D  Pupil dilation and Decreased sweat gland secretion

A  “I will review any over-the-counter medications with my health care provider.”

B  “I will take the medication 30 minutes before meals.”

C  “The medical alert in my health care record should cover me.”

D  “I hope to feel improvement in muscle strength.”

A  Add more stimuli to the environment

B  A walking program at least once a week

C  Limit sleep during the day

D  Increased responsibility for self-care

A  Neurologic status, Cardiovascular status, Gastrourinary (GU) status, Assess for suicidal tendencies

B  Pain assessment, Complete blood count, Gastrourinary (GU) status, Assess for suicidal tendencies

C  Cardiovascular status, Gastrourinary (GU) status, Pain assessment, Complete blood count

D  Cardiovascular status, Pain assessment, Complete blood count, Neurologic status

A  Ataxia and Cramps

B  Ataxia and Bleeding

C  Diarrhea and Syncope

D  Bleeding and Cramps

A  Stop the medication if you have headaches. Eat something if you feel nauseated. You may have some trouble sleeping. Tell your health care provider if you have stomach pains.

B  Get up slowly. Eat something if you feel nauseated. You may have some trouble sleeping. Stop the medication if you have headaches.

C  Get up slowly. Eat something if you feel nauseated. Stop the medication if you have headaches. Tell your health care provider if you have stomach pains.

D  Get up slowly. Eat something if you feel nauseated. You may have some trouble sleeping. Tell your health care provider if you have stomach pains.

A  Urinary retention from neurogenic atony of the bladder

B  Peptic ulcer and nonobstructive urinary retention

C  Post orthopedic surgery, low urinary output and bronchial wheezing

D  Decreased urination with possible renal calculi

A  Diagnose and treat myasthenia gravis. An antidote in biochemical warfare. An antidote to tricyclic antidepressant toxicity

B  An antidote to tricyclic antidepressant toxicity. Relieve severe constriction of the bronchioles. Treat a patient with a prolonged history of sleep deprivation

C  Relieve severe constriction of the bronchioles. Diagnose and treat myasthenia gravis. Treat a patient with a prolonged history of sleep deprivation

D  Relieve severe constriction of the bronchioles. Treat a patient with a prolonged history of sleep deprivation. An antidote in biochemical warfare

A  “Do not take the medication if you feel tired.”
“Take the medication on an empty stomach.”
“Get up slowly from a sitting or lying position.”

B  “Tell your health care provider if you have gastric pain that does not subside.”
“Do not take the medication if you feel tired.”
“Take the medication on an empty stomach.”

C  “Do not take the medication if you feel tired.”
“Take the medication on an empty stomach.”
“Your drug dose will be gradually increased.”

D  “Your drug dose will be gradually increased.”
“Get up slowly from a sitting or lying position.”
“Tell your health care provider if you have gastric pain that does not subside.”

A  10 mg

B  12 mg

C  7 mg

D  18 mg

A  Inject bethanechol. Provide a high-fiber diet. Administer a stool softener. Administer atropine. Increase fluid intake as tolerated.

B  Inject bethanechol. Administer atropine. Administer a stool softener. Ambulate the patient as tolerated. Increase fluid intake as tolerated.

C  Inject bethanechol. Provide a high-fiber diet. Administer a stool softener. Ambulate the patient as tolerated. Increase fluid intake as tolerated.

D  Administer atropine. Provide a high-fiber diet. Administer a stool softener. Ambulate the patient as tolerated. Increase fluid intake as tolerated.

A  Orthostatic hypotension, Hypoglycemia, Hypothyroidism

B  Bronchoconstriction, Hypoglycemia, Hypothyroidism

C  Dyspnea, Bronchoconstriction, Orthostatic hypotension

D  Hypoglycemia, Hypothyroidism, Dyspnea

A  2 mg

B  5 mg

C  10 mg

D  7 mg

A  Cognitive stabilization for a few months

B  Temporary improvement in cognitive skills

C  Rapid cognitive changes with decline

D  Gradual decrease in cognitive function

A  Nicotinic-receptor stimulation causes increased contraction of skeletal muscle. Nicotinic-receptor stimulation causes dilation of the pupils. Muscarinic-receptor stimulation causes constriction of blood vessels.

B  Nicotinic-receptor stimulation causes dilation of the pupils. Muscarinic-receptor stimulation causes constriction of blood vessels. Nicotinic-receptor stimulation causes increased blood pressure.

C  Nicotinic-receptor stimulation causes dilation of the pupils. Muscarinic-receptor stimulation causes constriction of blood vessels. Muscarinic-receptor stimulation causes increased gastrointestinal motility.

D  Nicotinic-receptor stimulation causes increased blood pressure. Muscarinic-receptor stimulation causes increased gastrointestinal motility. Nicotinic-receptor stimulation causes increased contraction of skeletal muscle.

A  “Seek medical help if you develop nausea and vomiting.”

B  “Take the medication 30 minutes after eating.”

C  “Notify your health care provider if you have a headache.”

D  “Do not eat solid food.”

A  Hypothyroidism, Psoriatic arthritis.

B  Emphysema, Hypothyroidism

C  Emphysema, Psoriatic arthritis.

D  Asthma, Coronary artery disease

A  Insomnia, Hypotension, Gastrointestinal (GI) upset

B  Ataxia, Dyspnea, Hypotension

C  Gastrointestinal (GI) upset, Ataxia, Dyspnea

D  Ataxia, Insomnia, Dyspnea

A  “The medication has an onset of action of about 3 weeks.”

B  “I will call the health care provider and ask for the medication to be changed.”

C  “Let me assess what other medications the patient is taking.”

D  “Sometimes family members aren’t the best at assessing these things.”

A  Bowel sounds

B  Blood glucose level

C  Body mass index

D  Vital signs

A  Rivastigmine

B  Donepezil

C  Galantamine

D  Memantine

A  Increase fluid intake to increase blood volume.

B  Take ibuprofen before rising.

C  Move from a sitting to standing position slowly.

D  Call for someone before rising.

A  Memantine

B  Bethanechol

C  Edrophonium

D  Physostigmine

A  Blood pressure 150/95 mm Hg

B  Constipation

C  Heart rate 30 beats/min

D  Respiratory rate 24 breaths/min

A  “My family says that my memory has improved.”

B  “I can tell my muscle strength has gotten better.”

C  “I feel like I am coughing up more phlegm.”

D  “I have noticed that I have been urinating more frequently.”

A  “You will take this medication once per week.”

B  “Be cautious with activity until you know how the medication affects you.”

C  “Do not drink grapefruit juice while on this medication.”

D  “Do not take this medication with food.”

A  Donepezil, Neostigmine, Memantine

B  Neostigmine, Pyridostigmine, Physostigmine

C  Physostigmine, Donepezil, Memantine

D  Donepezil, Memantine, Pyridostigmine

A  Respiratory rate 30 breaths/min

B  Blood pressure 70/40 mm Hg

C  Raised, erythematous rash

D  Inability to sleep

A  Sweating, Dizziness, Bradycardia, Hypotension

B  Dry cough, Dizziness, Bradycardia, Hypotension

C  Sweating, Dizziness, Bradycardia, Dry cough

D  Sweating, Dizziness, Dry cough, Hypotension

A  An antihistamine intravenously

B  Physostigmine intravenously

C  Dextrose solution intravenously

D  A high dose of donepezil orally

A  Urinary

B  Neurologic

C  Gastrointestinal

D  Musculoskeletal

A  Galantamine and Edrophonium

B  Neostigmine and Galantamine

C  Neostigmine and Edrophonium

D  Pilocarpine and Succinylcholine

A  Urination

B  Increased cognition

C  Wakefulness

D  Relaxed muscles

A  Chronic refractory heartburn

B  Urinary retention

C  Hyperthyroidism

D  Gastric atony

A  Bethanechol

B  Donepezil

C  Pyridostigmine

D  Memantine

A  Intramuscular

B  Oral

C  Ocular

D  Intravenous

A  Assess the patient’s breath sounds.

B  Administer epinephrine.

C  Monitor the patient’s heart rate.

D  Measure the patient’s urinary output.

A  Donepezil

B  Cevimeline

C  Succinylcholine

D  Bethanechol

A  Rivastigmine

B  Memantine

C  Epinephrine

D  Atropine

A  Pilocarpine

B  Succinylcholine

C  Neostigmine

D  Rivastigmine

A  Echothiophate

B  Atropine

C  Donepezil

D  Pyridostigmine

A  Carbachol

B  Tacrine

C  Memantine

D  Physostigmine

A  Cataracts

B  Macular degeneration

C  Dry eye syndrome

D  Glaucoma

A  Donepezil

B  Memantine

C  Rivastigmine

D  Atropine

A  Postoperative hypotension

B  Urinary atony

C  Respiratory atelectasis

D  Postoperative ischemic colitis

A  Ability to swallow without difficulty

B  Decreased respiration

C  Ability to speak clearly

D  Increased arm strength

A  Increased responsibility for self-care

B  A walking program at least once a week

C  Limit sleep during the day

D  Add more stimuli to the environment

A  “I will take the medication 30 minutes before meals.”

B  “I will review any over-the-counter medications with my health care provider.”

C  “I hope to feel improvement in muscle strength.”

D  “The medical alert in my health care record should cover me.”

A  Atropine available for immediate use. Epinephrine available for immediate use. Electroencephalogram ready to place. Blood pressure equipment for frequent monitoring.

B  Atropine available for immediate use. Epinephrine available for immediate use. Telemetry monitor on the patient. Electroencephalogram ready to place.

C  Atropine available for immediate use. Epinephrine available for immediate use. Telemetry monitor on the patient.Blood pressure equipment for frequent monitoring.

D  Atropine available for immediate use. Electroencephalogram ready to place. Telemetry monitor on the patient. Blood pressure equipment for frequent monitoring.

A  Urinary retention and Dry mouth

B  Dry mouth and Hypoactive bowel sounds

C  Nausea and Apical pulse of 56 beats per minute

D  Urinary retention and Hypoactive bowel sounds

A  Oral disintegrating tablets

B  Liquid oral solutions

C  Nasal spray

D  Subcutaneous infusions